Researchers at the School of Medicine have discovered an ingredient vital for proper blood vessel formation that explains why numerous promising treatments have failed. The discovery offers important direction for efforts to better treat a host of serious conditions ranging from diabetes to heart attacks and strokes.
Until now, scientists seeking to grow blood vessels have focused almost exclusively on growing only the inner layer of blood vessels, which are made up of endothelial cells. The hope was that these endothelial cells would then recruit any other cell types needed to form a complete, functional blood vessel. But researchers led by Gary K. Owens, PhD, director of UVA’s Robert M. Berne Cardiovascular Research Center, have determined that those vessels can develop properly only if they’re grown in conjunction with another cell type, known as perivascular cells, including smooth muscle cells and pericytes. The researchers liken these perivascular cells to the outer support layers of a rubber hose or on automobile tires, without which they burst or leak.
“Most of the studies of angiogenesis [blood vessel formation] have focused on the inner lining of the pipes themselves,” researcher Daniel L. Hess said. “That’s fairly well understood. But it’s really not well understood how you get a complete functional blood vessel that can withstand the mechanical force exerted by blood pressure.”
UVA’s new discovery helps answer that – and, in so doing, saves scientists from the time, effort and cost of pursuing treatment strategies that will ultimately bear no fruit.
Innovation and Collaboration
The discovery was made possible by the fortuitous convergence of research in two different labs at UVA. Hess was working on a model of peripheral artery disease in the labs of Owens and UVA’s Brian Annex, MD, in the Robert M. Berne Cardiovascular Research Center, while another researcher, Molly R. Kelly-Goss, was working with a model of blood vessel growth she developed in the lab of Shayn M. Peirce, PhD, of UVA’s Department of Biomedical Engineering.
By bringing those two models together, the researchers were able to determine the vital role of the perivascular cells in blood vessel formation and to identify a gene, Oct4, that is required for this process. Previously, Oct4 had been thought to be active only in embryonic stem cells during early development and to be permanently inactivated in adult organisms. This belief persisted until two years ago, when the Owens lab showed it was reactivated within smooth muscle cells during formation of atherosclerotic plaques inside blood vessels and required for formation of a protective fibrous cap on those lesions that prevents them from rupturing and setting off a heart attack or stroke – analogous to a patch on a tire. Now the lab has shown that Oct4 has an important role in the formation of the vessels themselves – ironically, being required for forming the protective outer wall of blood vessels.
Using Kelly-Goss’ model, the researchers were able to examine blood vessel formation in real time. They found that vessels that lacked perivascular cell coverage formed incompletely and leaked blood. “Multiple failed trials assumed the perivascular cells were just passive followers,” Owens explained. But without them, he said, “the whole process comes to a halt.” Importantly, they found that endothelial cells and perivascular cells communicate with one another via Oct4-dependent processes and, without it, functional non-leaky blood vessels or blood vessel networks cannot form.
Ultimately, that means that scientists must take a more sophisticated approach to growing new vessels, a process important in normal growth and reproduction as well as wound repair.
Blood Vessel Findings Published
The researchers have published their findings in the scientific journal Nature Communications. The research team consisted of Hess, Kelly-Goss, Olga A. Cherepanova, Anh T. Nguyen, Richard A. Baylis, Svyatoslav Tkachenko, Annex, Peirce and Owens.
The work was supported by the American Heart Association, including through Innovative Research Grant 17IRG33370017; the National Institutes of Health, grants R01 HL082838, R01 Ey022063, 1R01 HL12635, 1R01 HL116455, 2R01 HL101200, R01 HL057353, R01 HL135018 and T32 HL007284; the Hartwell Foundation; and the Wagner Fellowship.
To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.